Infliximab for Treatment of Axial Spondyloarthritis (P05336 AM1)

NCT00844805 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

158

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis
Axial Spondyloarthritis

Interventions

DRUG: Infliximab
DRUG: Placebo
DRUG: Naproxen

Sponsor

Merck Sharp & Dohme LLC